Monthly Archives: January 2018

How neighborhoods shape life with diabetes – Reuters

ReutersHow neighborhoods shape life with diabetesReutersCommunities with lower employment, income and education that have scant resources to support exercise and healthy eating have long been linked to an increased risk of developing diabetes. For the … Continue reading

Comments Off on How neighborhoods shape life with diabetes – Reuters

Johnson & Johnson is trying to sell its diabetes care business to Chinese buyers for up to $4 billion – CNBC


CNBC

Johnson & Johnson is trying to sell its diabetes care business to Chinese buyers for up to $4 billion
CNBC
Chinese bidders are circling a diabetes care business owned by the world’s largest healthcare company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters. New Brunswick, N.J.-based J&J said in

and more »

Continue reading

Comments Off on Johnson & Johnson is trying to sell its diabetes care business to Chinese buyers for up to $4 billion – CNBC

Women who have gestational diabetes in pregnancy are at higher risk of future health issues – Science Daily

Women who have gestational diabetes in pregnancy are at higher risk of future health issues
Science Daily
Dr Krish Nirantharakumar, of the University of Birmingham’s Institute of Applied Health Research, said: “Results showed women diagnosed with GDM were significantly more likely to develop hypertension and ischemic heart disease at a relatively young age

and more »

Continue reading

Comments Off on Women who have gestational diabetes in pregnancy are at higher risk of future health issues – Science Daily

New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes – Medscape

MedscapeNew Japanese Drug Pemafibrate Improves Lipid Profiles in DiabetesMedscapePemafibrate (Kowa Company), a novel selective peroxisome proliferator-activated receptor alpha (PPARα) modulator (or fibrate), may significantly improve lipid profiles and… Continue reading

Comments Off on New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes – Medscape

Endothelial cell loss higher in cataract patients with diabetes – Healio

Endothelial cell loss higher in cataract patients with diabetesHealioWAILEA, Hawaii — Clinicians should preoperatively discuss the effects of cataract surgery, specifically endothelial cell loss, with high-risk patients with diabetes, according to a sp… Continue reading

Comments Off on Endothelial cell loss higher in cataract patients with diabetes – Healio

Could It Be Diabetes? – Highlands Current

Highlands CurrentCould It Be Diabetes?Highlands CurrentFrank Milkovich, 84, of Cold Spring, was in his 50s when he was diagnosed with Type 2 diabetes. As part of an initiative by Lions Club International, he is distributing bookmarks to educate people … Continue reading

Comments Off on Could It Be Diabetes? – Highlands Current

Could It Be Diabetes? – Highlands Current

Highlands CurrentCould It Be Diabetes?Highlands CurrentFrank Milkovich, 84, of Cold Spring, was in his 50s when he was diagnosed with Type 2 diabetes. As part of an initiative by Lions Club International, he is distributing bookmarks to educate people … Continue reading

Comments Off on Could It Be Diabetes? – Highlands Current

Higher BUN May Increase Risk for Incident Diabetes – Endocrinology Advisor

Endocrinology AdvisorHigher BUN May Increase Risk for Incident DiabetesEndocrinology AdvisorHigher levels of blood urea nitrogen (BUN) are associated with an increased risk for incident diabetes, according to a study published in Kidney International.1… Continue reading

Comments Off on Higher BUN May Increase Risk for Incident Diabetes – Endocrinology Advisor

Diabetes and Drugs: The Weight Loss Dilemma – Pharmacy Times

Diabetes and Drugs: The Weight Loss DilemmaPharmacy TimesThe FDA has approved orlistat (an intestinal lipase inhibitor), liraglutide (a GLP-1 RA), lorcaserin (a 5-hydroxytryptamine2C serotonin receptor agonist), combination treatment of phentermine (ce… Continue reading

Comments Off on Diabetes and Drugs: The Weight Loss Dilemma – Pharmacy Times

Diabetes and Drugs: The Weight Loss Dilemma – Pharmacy Times

Diabetes and Drugs: The Weight Loss DilemmaPharmacy TimesThe FDA has approved orlistat (an intestinal lipase inhibitor), liraglutide (a GLP-1 RA), lorcaserin (a 5-hydroxytryptamine2C serotonin receptor agonist), combination treatment of phentermine (ce… Continue reading

Comments Off on Diabetes and Drugs: The Weight Loss Dilemma – Pharmacy Times